Medical cannabis use in Canadians with multiple sclerosis.
暂无分享,去创建一个
[1] R. Tsuyuki,et al. Measuring the Effects of Nurse-Practitioner (NP)-Led Care on Depression and Anxiety Levels in People with Multiple Sclerosis: A Study Protocol for a Randomized Controlled Trial , 2021 .
[2] A. Oturai,et al. Illegal cannabis use is common among Danes with multiple sclerosis. , 2019, Multiple sclerosis and related disorders.
[3] G. Giovannoni,et al. Multiple sclerosis – a review , 2018, European journal of neurology.
[4] Raed Alroughani,et al. Multiple Sclerosis , 2018, Seminars in Neurology.
[5] Chelsea Cox. The Canadian Cannabis Act legalizes and regulates recreational cannabis use in 2018. , 2018, Health policy.
[6] L. Degenhardt,et al. The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews , 2018, Current Neurology and Neuroscience Reports.
[7] Suzy L. Wong,et al. Multiple sclerosis: Prevalence and impact. , 2018, Health reports.
[8] R. Tandon,et al. Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders , 2017, Current neuropharmacology.
[9] A. Feinstein,et al. Cannabis and cognitive functioning in multiple sclerosis: The role of gender , 2017, Multiple sclerosis journal - experimental, translational and clinical.
[10] G. Ko,et al. Medical cannabis – the Canadian perspective , 2016, Journal of pain research.
[11] A. Feinstein,et al. What to make of cannabis and cognition in MS: In search of clarity amidst the haze , 2015, Multiple sclerosis.
[12] J. Bronstein,et al. Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders , 2014, Neurology.
[13] Robert W Motl,et al. Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis , 2013, BMC Neurology.
[14] Ethan B. Russo. Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects , 2011, British journal of pharmacology.
[15] M. Tierney,et al. Effects of cannabis on cognitive function in patients with multiple sclerosis , 2011, Neurology.
[16] P. Sørensen,et al. The changing demographic pattern of multiple sclerosis epidemiology , 2010, The Lancet Neurology.
[17] T. J. Murray,et al. Patterns of cannabis use among patients with multiple sclerosis , 2004, Neurology.
[18] R. Stebbins,et al. Cannabis Use as Described by People with Multiple Sclerosis , 2003, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[19] G. W. Ellison,et al. A health-related quality of life measure for multiple sclerosis , 1995, Quality of Life Research.
[20] C. Bever,et al. Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis , 2014, Neurology.